Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

LONDON--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Zacks Research dropped their Q1 2025 EPS estimates for shares of Edwards ...

On Friday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.48 which represents a slight increase of $0.10 or 0.14% from the prior close of $70.38. The stock opened at ...

On Thursday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.38 which represents a slight increase of $0.84 or 1.21% from the prior close of $69.54. The stock opened at ...

Leavell Investment Management Inc. boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 3.3% ...

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE ...

Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic ...